光谱组织病理学解决肺癌诊断的观察者间差异
该研究基于249例患者的328份样本,采用光谱组织病理学(SHP)进行肺组织分类,证明SHP区分肺腺癌与鳞状细胞癌的准确性可与免疫组化媲美,并能高度可靠地分类腺鳞癌,还可用于解决肺病理中的观察者间差异。
要点
- SHP基于物理测量,比形态学方法更客观可重复。
- SHP区分肺腺癌与鳞癌的准确性可与免疫组化相比。
- SHP能高度可靠地分类腺鳞癌并解决观察者间差异。
核心结论
- SHP可区分肺腺癌与鳞状细胞癌,准确性可与免疫组化媲美。
- SHP能高度可靠地分类腺鳞癌。
- SHP可用于解决肺病理中的观察者间差异。
研究设计与样本
- 研究纳入249例患者的328份样本,为City of Hope癌症中心与CIRECA公司的合作研究。
- 采用光谱组织病理学(SHP)进行组织分类。
主要发现
- SHP区分肺腺癌与鳞状细胞癌的准确性可与免疫组化媲美。
- SHP对腺鳞癌的分类高度可靠。
- SHP能解决肺病理中的观察者间差异。
- SHP基于生化组成变化检测,而非形态学特征。
临床怎么用
- SHP可作为一种客观可重复的辅助手段,用于肺腺癌、鳞癌及腺鳞癌的分类。
- SHP可用于解决肺病理诊断中的观察者间差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This paper reports the results of a collaborative lung cancer study between City of Hope Cancer Center (Duarte, California) and CIRECA, LLC (Cambridge, Massachusetts), comprising 328 samples from 249 patients, that used an optical technique known as spectral histopathology (SHP) for tissue classification. Because SHP is based on a physical measurement, it renders diagnoses on a more objective and reproducible basis than methods based on assessing cell morphology and tissue architecture. This report demonstrates that SHP provides distinction of adenocarcinomas from squamous cell carcinomas of the lung with an accuracy comparable to that of immunohistochemistry and highly reliable classification of adenosquamous carcinoma. Furthermore, this report shows that SHP can be used to resolve interobserver differences in lung pathology. Spectral histopathology is based on the detection of changes in biochemical composition, rather than morphologic features, and is therefore more akin to methods such as matrix-assisted laser desorption ionization time-of-flight mass spectrometry imaging. Both matrix-assisted laser desorption ionization time-of-flight mass spectrometry and SHP imaging modalities demonstrate that changes in tissue morphologic features observed in classical pathology are accompanied by, and may be correlated to, changes in the biochemical composition at the cellular level. Thus, these imaging methods provide novel insight into biochemical changes due to disease.
引用
- Akalin A, Ergin A, Remiszewski S, et al. Resolving Interobserver Discrepancies in Lung Cancer Diagnoses by Spectral Histopathology. Arch Pathol Lab Med. 2018. PMID: 30141697. doi:10.5858/arpa.2017-0476-SA
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。